Table II.
Groups | TNF-α [pg/ml] | VEGF [pg/ml] | AFP [ng/ml] |
---|---|---|---|
Normal control | 116.8 ±6.8 | 120.2 ±1.48 | 3.72 ±0.09 |
Nano control | 110.5 ±9.7 | 121.50 ±1.42 | 3.28 ±0.29 |
Free cur. HD | 103.3 ±9.2 | 126.42 ±1.53 | 4.00 ±0.27 |
Free cur. LD | 121.3 ±8.4 | 127.37 ±1.33 | 4.03 ±0.18 |
Nano cur. HD | 118.0 ±5.2 | 122.62 ±2.18 | 4.01 ±0.16 |
Nano cur. LD | 132.4 ±3.4 | 119.67 ±1.52 | 3.93 ±0.11 |
DEN | 484.9 ±94.3a | 531.27 ±7.76a | 55.72 ±0.89a |
DEN + Free cur. HD | 210.8 ±19.3** | 360.53 ±3.93** | 17.58 ±0.66** |
DEN + Free cur. LD | 238.1 ±39.9** | 401.38 ±6.58** | 19.57 ±0.59** |
DEN + Nano cur. HD | 142.8 ±11.8** | 191.07 ±2.84** | 9.12 ±0.26** |
DEN + Nano cur. LD | 179.3 ±15.7** | 256.90 ±3.37** | 14.58 ±0.59** |
Results are expressed as mean ± SE.
p < 0.01 significantly higher than normal
p < 0.01 significantly lower than DEN.
TNF-α – tumor necrosis factor-α, VEGF – vascular endothelial growth factor, AFP – α-fetoprotein.